Other countries select ‘incentives’ over ‘obligation’ to promote inexpensive drugs

Other countries are reportedly taking various policies for the use of inexpensive drugs, such as nonproprietary names and incentives for generic substitutions.

These policies are carried out with various methods in different countries; they were mostly focusing on provision of economic benefits, not obligation.

The Pharmaceutical Technology Research Team at the Health Insurance & Assessment S...